I have worked as a GP (family doctor) in central London for over 20 years. I left the NHS in 2009 to concentrate on my interests of childhood immunisation.

I founded
BabyJabs, a unique dedicated children’s immunisation service in London where I work as medical director. We offer parents a choice of single and small combination vaccines for their child and, in consultation with parents, prepare personalised immunisation schedules for children, taking into account their personal situation and needs.
Stacks Image 1602
Stacks Image 288
I am concerned that the vaccine ‘debate’ is often polarised between those who are either obsessively pro-vaccine or totally opposed to any sort of vaccination. I find both these viewpoints extreme and unhelpful to parents who are confused and unsure about which immunisations to give their child.
I am not anti-vaccine (I wouldn’t run an immunisation clinic if I were) but I do have concerns about the quantity and frequency of vaccines given to very young babies.
I spent many years researching children’s vaccines, and have written up my findings in my book, The Truth about Vaccines which was first published in 2007.
An much expanded and updated 4th edition, entitled
Vaccines: making the right choice for your child, was published in 2018. This includes information on all the main children's vaccines and diseases they protect against. I describe how and when vaccines were introduced, their effectiveness and side-effects. The book also includes alternative vaccines schedules available both privately and on the NHS. Buy this book from amazon.

Latest News

Aluminium in vaccines has not been shown to be safe

Very little research has ben done into the safety of aluminium in vaccines and what little research there has been does not demonstrate safety.

My recent appearance on Frabce 24 TV

I recently appeared on France 24 Tv to talk about vaccines. Watch the interview here.

Delaying vaccination reduces risk of eczema

Delaying the first DTaP vaccine by as little as one month can reduce eczema risk by nearly 50 per cent.